ReviewAnnals of the rheumatic diseases2004

Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004.

D E Furst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.